Open Access<p>Comparison of Relapse Prevention with 3 Different Paliperidone Formulations in Patients with Schizophrenia Continuing versus Discontinuing Active Antipsychotic Treatment: A Post-Hoc Analysis of 3 Similarly Designed Randomized Studies</p>
Author(s) -
Maju Mathews,
Srihari Gopal,
Arun Singh,
Isaac Nuamah,
Katalin Pungor,
Wilson M. Tan,
Bernardo Soares,
Edward Kim,
Adam Savitz
Publication year - 2020
Publication title -
neuropsychiatric disease and treatment
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.819
H-Index - 67
eISSN - 1178-2021
pISSN - 1176-6328
DOI - 10.2147/ndt.s221242
Subject(s) - paliperidone , paliperidone palmitate , medicine , discontinuation , antipsychotic , post hoc analysis , placebo , hazard ratio , schizophrenia (object oriented programming) , pharmacology , confidence interval , psychiatry , alternative medicine , pathology
Sudden discontinuation from antipsychotic treatment is a common occurrence in patients with schizophrenia. Lower rates of relapse could be expected for patients discontinuing treatment from longer-acting formulations vs their shorter-acting equivalents.